Anti-SV2B/ HsT19680 monoclonal antibody

Anti-SV2B/ HsT19680 antibody for FACS & in-vivo assay

Target products collectionGo to SV2B/SV2B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1735-Ab-1/ GM-Tg-hg-MP1735-Ab-2Anti-Human SV2B monoclonal antibodyHuman
GM-Tg-rg-MP1735-Ab-1/ GM-Tg-rg-MP1735-Ab-2Anti-Rat SV2B monoclonal antibodyRat
GM-Tg-mg-MP1735-Ab-1/ GM-Tg-mg-MP1735-Ab-2Anti-Mouse SV2B monoclonal antibodyMouse
GM-Tg-cynog-MP1735-Ab-1/ GM-Tg-cynog-MP1735-Ab-2Anti-Cynomolgus/ Rhesus macaque SV2B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1735-Ab-1/ GM-Tg-felg-MP1735-Ab-2Anti-Feline SV2B monoclonal antibodyFeline
GM-Tg-cang-MP1735-Ab-1/ GM-Tg-cang-MP1735-Ab-2Anti-Canine SV2B monoclonal antibodyCanine
GM-Tg-bovg-MP1735-Ab-1/ GM-Tg-bovg-MP1735-Ab-2Anti-Bovine SV2B monoclonal antibodyBovine
GM-Tg-equg-MP1735-Ab-1/ GM-Tg-equg-MP1735-Ab-2Anti-Equine SV2B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1735-Ab-1/ GM-Tg-hg-MP1735-Ab-2; GM-Tg-rg-MP1735-Ab-1/ GM-Tg-rg-MP1735-Ab-2;
GM-Tg-mg-MP1735-Ab-1/ GM-Tg-mg-MP1735-Ab-2; GM-Tg-cynog-MP1735-Ab-1/ GM-Tg-cynog-MP1735-Ab-2;
GM-Tg-felg-MP1735-Ab-1/ GM-Tg-felg-MP1735-Ab-2; GM-Tg-cang-MP1735-Ab-1/ GM-Tg-cang-MP1735-Ab-2;
GM-Tg-bovg-MP1735-Ab-1/ GM-Tg-bovg-MP1735-Ab-2; GM-Tg-equg-MP1735-Ab-1/ GM-Tg-equg-MP1735-Ab-2
Products NameAnti-SV2B monoclonal antibody
Formatmab
Target NameSV2B
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SV2B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SV2B/ HsT19680 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1735
    Target NameSV2B
    Gene ID9899,64176,117556,710980,488723,101093273,527014,100070267
    Gene Symbol and SynonymsA830038F04Rik,HsT19680,mKIAA0735,SLC22B2,SV2B
    Uniprot AccessionQ7L1I2,Q63564
    Uniprot Entry NameSV2B_HUMAN,SV2B_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000185518
    Target ClassificationN/A

    The target: SV2B, gene name: SV2B, also named as HsT19680. This gene encodes a member of the synaptic vesicle proteins 2 (SV2) family and major facilitator superfamily of proteins. This protein and other members of the family are localized to synaptic vesicles and may function in the regulation of vesicle trafficking and exocytosis. Studies in mice suggest that the encoded protein may act as a protein receptor for botulinum neurotoxin E in neurons, and that this protein may be important for the integrity of the glomerular filtration barrier. This gene shows reduced expression in areas of synaptic loss in the hippocampus of human temporal lobe epilepsy patients. [provided by RefSeq, Sep 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.